Table 5 Cox survival analysis for CVC vs. AVF/PD catheter access

Complete cohort (n = 406)

Unadjusted

1.70 [1.20 to 2.41]

0.003

Model 1^a

1.73 [1.22 to 2.45]

0.002

Model 2^b

1.55 [1.08 to 2.22]

0.02

Model 3^c

1.41 [0.97 to 2.05]

0.07

Model 4^d

1.19 [0.80 to 1.77]

0.40

Model 4^d without censoring at transplantation

1.16 [0.78 to 1.73]

0.45

Excluding acute start patients (n = 349)

Unadjusted

1.36 [0.93 to 2.00]

0.11

Model 1^a

1.42 [0.97 to 2.09]

0.07

Model 2^b

1.28 [0.87 to 1.90]

0.21

Model 3^c

1.23 [0.83 to 1.84]

0.30

Model 4^d

1.03 [0.67 to 1.57]

0.91

Model 4^d without censoring at transplantation

0.99 [0.64 to 1.51]

0.95

Excluding acute start patients with an eGFR > 30 ml/min/1.73 m ² (n = 359)

Unadjusted

1.42 [0.97 to 2.06]

0.07

Model 1^a

1.46 [1.00 to 2.13]

0.05

Model 2^b

1.32 [0.89 to 1.94]

0.16

Model 3^c

1.26 [0.85 to 1.87]

0.24

Model 4^d

1.05 [0.69 to 1.61]

0.81

Model 4^d without censoring at transplantation

1.02 [0.67 to 1.55]

0.94